OR WAIT null SECS
May 29, 2014
The Bulk Pharmaceuticals Task Force asks FDA to respond to concerns about reduction in API facility compliance inspections.
May 02, 2014
Drug developers are taking a wait-and-see approach to the use of cocrystals.
April 15, 2014
The author examines the effect of compaction force, gap width, and sieve setup on granule size.
April 02, 2014
Increasing potency and growing interest in antibody-drug conjugates are creating challenges for manufacturers of HPAPIs.
March 02, 2014
The commercial availability of an increasing diversity of enzymes has led to the growing use of biocatalysts for API synthesis.
February 02, 2014
Recent regulatory initiatives designed to secure the global pharmaceutical supply chain will directly impact the global supply chain and API manufacturers.
January 02, 2014
Emerging markets are an engine for growth in the custom-manufacturing and pharma markets.
December 02, 2013
PIC/S reviews deficiencies found during inspections of API manufacturing facilities, harmonizes GMP standards, and provides training for inspectors worldwide.
A review of this year's crop of the new molecular entities and new biologics license applications approved by FDA thus far in 2013.
November 02, 2013
Fine-chemical companies, contract manufacturers, and researchers advance chemocatalysis and biocatalysis.